Psychiatry, Psychobabble, & Psychoactive Drugs: Revised Edition

By Wylie Jones Jordan MD

The coinage of new names for the symptoms of mental disorders has given psychiatric diagnoses the semblance of identified diseases, but it has little or no clinical use. Unfamiliar new names just allow the pharmaceutical industry to produce and advertise symptom-blocking drugs as if they were medicine. The industry now produces an array of psychoactive drugs that are no less addictive than natural substances. Mood altering drugs have long been recognized as dangerously addictive, and the promotion of commercial drugs has created a nation life-long customers taking what they've been told are medicines.The astonishingly expensive 'war on drugs' only protects the sale of patented drugs from competition from less expensive natural substances. The 'war' is amazingly hypocritical: opium is prohibited but far more powerful opioids are legal; amphetamines can be advertised and nicotine is sold in e-cigarettes, while a related alkaloid, cocaine, is demonized. The map of mental functioning presented here is a practical approach to understanding which emotional problems will respond to drugs and which will not. It suggests a means of distinguishing nature from nurture and suggests a diagnostic system that supports a search for causes.

• Format: Paperback
• Language: English
• ISBN: 1092411879
• ISBN13: 9781092411875
• Release Date: April 2019
• Publisher: Independently published
• Length: 179 Pages
• Weight: 0.73 lbs.
• Dimensions: 9.0" x 0.4" x 6.0"